tradingkey.logo

Park Ha Biological Technology Co Ltd

PHH
0.385USD
0.0000.00%
Cierre 02/06, 16:00ETCotizaciones retrasadas 15 min
11.31MCap. mercado
--P/E TTM

Park Ha Biological Technology Co Ltd

0.385
0.0000.00%

Más Datos de Park Ha Biological Technology Co Ltd Compañía

Park Ha Biological Technology Co Ltd is an investment holding company primarily engaged in developing private skincare label, direct skincare products sales and franchise alliances promotions. The Company mainly operates its business through two segments. The Products Sales segment is engaged in providing skincare and cosmetic products under the brand name Park Ha as well as offering complimentary after-sales beauty services in physical stores. The Franchise Service segment is engaged in entering franchise agreements with its franchisees, pursuant to which the franchisees are granted permission to open and operate a store under the brand name Park Ha or Geni. The Company's products include Little Blue Injection Serum, Parkha Amino Acid Cleansing Foam and other products. The Company mainly conducts its business in domestic market.

Información de Park Ha Biological Technology Co Ltd

Símbolo de cotizaciónPHH
Nombre de la empresaPark Ha Biological Technology Co Ltd
Fecha de salida a bolsaDec 27, 2024
Director ejecutivoZhang (Xiaoqiu)
Número de empleados31
Tipo de seguridadOrdinary Share
Fin del año fiscalDec 27
Dirección- -
Ciudad- -
Bolsa de valoresNASDAQ Capital Market Consolidated
País- -
Código postal- -
Teléfono- -
Sitio Web- -
Símbolo de cotizaciónPHH
Fecha de salida a bolsaDec 27, 2024
Director ejecutivoZhang (Xiaoqiu)

Ejecutivos de Park Ha Biological Technology Co Ltd

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--
Mr. Xiaozhong Yu
Mr. Xiaozhong Yu
Independent Director Nominee
Independent Director Nominee
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Ms. Xiaoqiu Zhang
Ms. Xiaoqiu Zhang
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Ms. Li Wang
Ms. Li Wang
Director
Director
--
--
Ms. Xiaoyan Zhu
Ms. Xiaoyan Zhu
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Xinyu Li
Ms. Xinyu Li
Chief Technology Officer, Product Manager
Chief Technology Officer, Product Manager
--
--
Ms. Yanan Shan
Ms. Yanan Shan
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Qixiong Sheng
Mr. Qixiong Sheng
Independent Director
Independent Director
--
--

Desglose de ingresos

FY2024
FY2023
FY2022
FY2021
La empresa aún no ha revelado los datos relevantes.
Por regiónUSD
Nombre
Ganancia
Proporción
China (Mainland)
2.38M
0.00%
Por negocio
Por región
La empresa aún no ha revelado los datos relevantes.

Estadísticas de accionistas

Actualizado: lun., 17 de nov
Actualizado: lun., 17 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Xiaoqiu Holding Ltd
51.91%
Changxin International Ltd Partnership
6.81%
XTX Markets LLC
0.12%
Two Sigma Investments, LP
0.07%
Geode Capital Management, L.L.C.
0.05%
Otro
41.04%
Accionistas
Accionistas
Proporción
Xiaoqiu Holding Ltd
51.91%
Changxin International Ltd Partnership
6.81%
XTX Markets LLC
0.12%
Two Sigma Investments, LP
0.07%
Geode Capital Management, L.L.C.
0.05%
Otro
41.04%
Tipos de accionistas
Accionistas
Proporción
Corporation
58.72%
Venture Capital
0.12%
Hedge Fund
0.07%
Investment Advisor/Hedge Fund
0.05%
Research Firm
0.01%
Investment Advisor
0.01%
Otro
41.02%

Participación institucional

Actualizado: jue., 1 de ene
Actualizado: jue., 1 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
18
96.81K
0.26%
-57.60K
2025Q3
15
103.15K
0.30%
+40.70K
2025Q2
9
21.62M
81.98%
-25.58K
2025Q1
8
21.60M
81.90%
-29.47K
2024Q4
6
21.63M
82.55%
+21.63M

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Xiaoqiu Holding Ltd
19.05M
56.24%
--
--
Feb 24, 2025
Changxin International Ltd Partnership
2.50M
7.38%
--
--
Feb 24, 2025
XTX Markets LLC
43.55K
0.13%
+43.55K
--
Sep 30, 2025
Two Sigma Investments, LP
26.69K
0.08%
+26.69K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
16.85K
0.05%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
5.34K
0.02%
-1.68K
-23.94%
Sep 30, 2025
UBS Financial Services, Inc.
5.00K
0.01%
+3.53K
+239.88%
Sep 30, 2025
Morgan Stanley Smith Barney LLC
780.00
0%
+486.00
+165.31%
Sep 30, 2025
RBC Capital Markets Wealth Management
19.00
0%
--
--
Sep 30, 2025
Citadel Advisors LLC
--
0%
-21.23K
-100.00%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Invesco Golden Dragon China ETF
0%
Invesco Golden Dragon China ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI